文献速递介入神经骨肌CT

CT引导下阴部神经脉冲射频消融治疗慢性顽固性盆腔疼痛的初步经验

Initial experience of CT-guided pulsed radiofrequency ablation of the pudendal nerve for chronic recalcitrant pelvic pain.
PubMed 文献 · Clin Radiol · 2019-08-22

本研究评估CT引导下阴部神经脉冲射频消融(pRFA)治疗顽固性神经病理性盆腔疼痛的初步经验,10例患者接受治疗并随访6个月。所有手术技术成功且无即刻并发症;pRFA较最近一次神经周围注射疼痛改善持续时间延长(p=0.0195),但与首次注射相比无差异(p=0.64)。疼痛评分较首次和最近一次注射均降低但未达统计学显著(p=0.1094和p=0.7539)。结论认为该技术安全有效,可直接显示神经以提高安全性和疗效。

要点

  • CT引导下pRFA可直接显示阴部神经,所有10例手术技术成功且无即刻并发症。
  • pRFA后疼痛改善持续时间较最近一次神经周围注射延长(p=0.0195),但与首次注射无差异(p=0.64)。
  • pRFA后疼痛评分低于首次和最近一次注射,但均未达统计学显著(p=0.1094和p=0.7539)。

核心结论

  • CT引导下阴部神经pRFA可能是慢性顽固性盆腔疼痛安全有效的治疗方法,可直接显示神经以最大化安全性和疗效,并提供一种新型治疗形式。

研究设计与样本

  • 初步经验研究,纳入10例在试验期间因神经病理性阴部神经痛接受pRFA的患者,随访6个月;在CT引导下进行pRFA并同期行神经周围麻醉剂和/或皮质类固醇注射;采用数字评分量表在固定间隔测量疼痛评分至6个月。

诊断标准与关键数值

  • 所有手术被认为技术成功且无即刻并发症。
  • pRFA后疼痛改善持续时间较最近一次神经周围注射延长(p=0.0195),但与首次注射相比无差异(p=0.64)。
  • pRFA后疼痛评分低于首次注射和最近一次注射,但未达统计学显著(p=0.1094和p=0.7539)。

临床应用与阅片要点

  • 作者认为CT引导下pRFA使用CT可直接显示神经,从而最大化安全性和疗效,并为慢性顽固性盆腔疼痛患者提供一种新型治疗形式。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate initial experience with computed tomography (CT)-guided pulsed radiofrequency ablation (pRFA) of the pudendal nerve in cases of recalcitrant neuropathic pelvic pain. Endpoints include technical feasibility, safety, and efficacy of therapy.

MATERIALS AND METHODS: Ten patients who underwent pRFA ablation for neuropathic pudendal nerve pain during the trial period were followed for response to treatment for 6 months. Each patient was treated with pRFA under CT-guidance with concurrent perineural injection of anaesthetic and/or corticosteroid. Pain scores were then measured using a numeric rating scale at fixed intervals up to 6 months.

RESULTS: All procedures were considered technically successful with no immediate complications. pRFA demonstrated improved duration of pain improvement compared to the most recent perineural injection (p=0.0195), but not compared to the initial injection (p=0.64). Reported pain scores were lower with pRFA than with both the first and most recent injection but this did not reach statistical significance (p=0.1094 and p=0.7539, respectively).

CONCLUSION: Overall, pRFA of the pudendal nerve using CT-guidance can be a safe and effective therapy. This technique provides direct visualisation of the nerve to maximise safety and efficacy while offering a novel form of therapy for patients with chronic, recalcitrant pelvic pain.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Collard MD, Xi Y, Patel AA, et al. Initial experience of CT-guided pulsed radiofrequency ablation of the pudendal nerve for chronic recalcitrant pelvic pain. Clin Radiol. 2019. PMID: 31447049. doi:10.1016/j.crad.2019.06.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。